Back to the complete issue
Tuesday, 13 April 2021

MPs + senators begin lining up for their covid shots

MPs and members of the Senate began receiving their covid-19 jabs yesterdaya day after Prime Minister Moustafa Madbouly signed off on their eligibility, Youm7 reports. All MPs and senators will be vaccinated along with their immediate families. Rep. Mostafa Bakry had previously proposed that the entire House of Representatives go on recess until members are inoculated, after 15 MPs were infected.

The Health Ministry reported 818 new covid-19 infections yesterday, up from 801 the day before. Egypt has now disclosed a total of 211,307 confirmed cases of covid-19. The ministry also reported 42 new deaths, bringing the country’s total death toll to 12,487.

China can’t make up its mind on whether Sinopharm and Sinovac are effective: Beijing is walking back comments that its locally-made covid-19 vaccines “don't have very high protection rates,” with director of the China Centers for Disease Control Gao Fu saying his remarks had been “taken out of context,” the Financial Times reports. Fu told local media that he was suggesting that vaccines should be mixed to “optimise” China’s immunisation plan. “There are many scientific questions that need to be addressed,” Gao told Global Times.

By the numbers: The Sinovac shot, of which Egypt plans to produce 80 mn doses each year through state-owned Vacsera, was reportedly found to be just 50.4% effective at preventing symptomatic infections according to recently released data from a stage 3 trial in Brazil. Sinopharm, of which Egypt has so far received 680k doses, has claimed a higher 79% efficacy rate. We are expected to get our hands on an additional 900k-1 mn doses of the jab in the coming days.

A covid-19 antibody pill has proven to be 81% effective at reducing the risk of developing symptomatic covid-19 infection, according to a mid-stage study by Regeneron, who is now seeking to expand the use of its experimental antiviral med in the US as a preventative treatment, according to a statement.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Etisalat Misr (tax ID: 235-071-579), the leading telecoms provider in Egypt; and Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt.